Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-232551
Filing Date
2025-10-07
Accepted
2025-10-07 07:05:09
Documents
8

Document Format Files

Seq Description Document Type Size
1 424B5 2025_prosupp_pfw_without.htm 424B5 785573
2 GRAPHIC img52911964_0.jpg GRAPHIC 3030
3 GRAPHIC img52911964_1.jpg GRAPHIC 77352
4 GRAPHIC img52911964_2.jpg GRAPHIC 416226
5 GRAPHIC img52911964_3.jpg GRAPHIC 454986
6 GRAPHIC img52911964_4.jpg GRAPHIC 203895
7 GRAPHIC img52911964_5.jpg GRAPHIC 26591
8 GRAPHIC img52911964_6.jpg GRAPHIC 1935
  Complete submission text file 0001193125-25-232551.txt   2417460
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-285609 | Film No.: 251378240
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)